homocysteine has been researched along with Encephalopathy, Toxic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dave, M; Feuer, P; Ilahi, Z; Janardhan, S; Khariton, M; Romanos-Sirakis, E; Venkataraman, A | 1 |
| Fujimura, Y; Kumazoe, M; Kuriyama, S; Lin, TA; Maeda-Yamamoto, M; Marugame, Y; Mei, CY; Nakayama, K; Tachibana, H; Yamashita, S; Yoshitomi, R | 1 |
| Chao, X; Chen, M; Chen, X; Chen, Z; Gao, Y; Jin, M; Liu, P; Ouyang, Y; Pi, R; Ramassamy, C; Tan, M | 1 |
| Bhatia, P; Singh, N | 1 |
| Beckwith, KA; Cole, PD; Kamen, BA; Roychowdhury, S; Smith, AK; Vijayanathan, V | 1 |
| Chen, RQ; Fang, HR; Huang, YE; Ren, YK; Shen, XT; Tang, XQ; Wang, CY; Zhuang, YY | 1 |
| Bisschops, RH; Mali, WP; van der Graaf, Y; van der Grond, J | 1 |
| Charlton, CG; Chen, H; Lee, ES; Soliman, KF | 1 |
| Choi, D; Harris, RH; Kohn, H; Kupferberg, HJ; Stables, JP; Stöhr, T; Walton, N; White, HS | 1 |
| Becker, A; Bode, U; Jaehde, U; Linnebank, M; Pels, H; Schlegel, U; Vezmar, S | 1 |
1 review(s) available for homocysteine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Homocysteine excess: delineating the possible mechanism of neurotoxicity and depression.
Topics: Cysteine; Depression; Homocysteine; Humans; Hyperhomocysteinemia; Neurotoxicity Syndromes; S-Adenosylmethionine | 2015 |
1 trial(s) available for homocysteine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate.
Topics: Adult; Aged; Alleles; Antimetabolites, Antineoplastic; Brain Chemistry; Central Nervous System Neoplasms; Cytarabine; Excitatory Amino Acids; Female; Homocysteine; Humans; Injections, Intravenous; Injections, Intraventricular; Lymphoma; Male; Methotrexate; Middle Aged; Neurotoxicity Syndromes; Pilot Projects; S-Adenosylmethionine; Statistics, Nonparametric; Time Factors | 2007 |
8 other study(ies) available for homocysteine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Ketamine as an Adjunct for Treatment of Methotrexate-induced Neurotoxicity.
Topics: Child; Homocysteine; Humans; Ketamine; Methotrexate; Neurotoxicity Syndromes; Paresis | 2022 |
Plasma Homocysteine Concentration is Associated with the Expression Level of Folate Receptor 3.
Topics: Carrier Proteins; Cohort Studies; Dietary Supplements; Female; Folic Acid; HEK293 Cells; Homocysteine; Humans; Male; Middle Aged; Neurotoxicity Syndromes | 2020 |
Downregulation of Nrf2/HO-1 pathway and activation of JNK/c-Jun pathway are involved in homocysteic acid-induced cytotoxicity in HT-22 cells.
Topics: Animals; Anthracenes; Apoptosis; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Heme Oxygenase-1; Homocysteine; MAP Kinase Signaling System; Membrane Proteins; Mice; Mitochondria; Neurons; Neurotoxicity Syndromes; NF-E2-Related Factor 2; Oxidative Stress; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species | 2013 |
Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia.
Topics: Administration, Oral; Adolescent; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cognition; Dementia, Vascular; Folic Acid; Folic Acid Antagonists; Homeostasis; Homocysteine; Humans; Infant; Magnetic Resonance Imaging; Methotrexate; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; tau Proteins; Young Adult | 2009 |
Inhibition of endogenous hydrogen sulfide generation is associated with homocysteine-induced neurotoxicity: role of ERK1/2 activation.
Topics: Animals; Antioxidants; Cystathionine beta-Synthase; Enzyme Activation; Homocysteine; Hydrogen Sulfide; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurotoxicity Syndromes; PC12 Cells; Rats; Reactive Oxygen Species | 2011 |
Elevated levels of plasma homocysteine are associated with neurotoxicity.
Topics: Aged; Biomarkers; Comorbidity; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurotoxicity Syndromes; Probability; Risk Assessment; Sampling Studies; Sensitivity and Specificity; Statistics, Nonparametric | 2004 |
Effects of homocysteine on the dopaminergic system and behavior in rodents.
Topics: Adenosine; Animals; Behavior, Animal; Brain Chemistry; Catheterization; Chromatography, High Pressure Liquid; Dopamine; Homocysteine; Immunohistochemistry; Injections, Intraventricular; Male; Methylation; Mice; Mice, Inbred C57BL; Motor Activity; Neostriatum; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine; Tyrosine 3-Monooxygenase | 2005 |
Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
Topics: Acetamides; Animals; Anticonvulsants; Bicuculline; Cobalt; Convulsants; Electroshock; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Epilepsy, Reflex; Excitatory Amino Acid Agonists; GABA Antagonists; Homocysteine; Kindling, Neurologic; Lacosamide; Male; Mice; N-Methylaspartate; Neurotoxicity Syndromes; Pentylenetetrazole; Picrotoxin; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2007 |